APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Menopause Hormonal Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Menopause Hormonal Treatment Industry Growth and Trends Forecast to 2032

Report ID 174012050122 December 2025103 pages

Choose your research edition.

Industry ResearchMenopause Hormonal Treatment Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Menopause Hormonal Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Menopause Hormonal Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Menopause Hormonal Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Menopause Hormonal Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Menopause Hormonal Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Menopause Hormonal Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Menopause Hormonal Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Menopause Hormonal Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Menopause Hormonal Treatment include Teva Pharmaceutical Industries, Novartis, Novo Nordisk, Merck, Eli Lilly And Company, Pfizer, Bayer, AbbVie and Theramex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Menopause Hormonal Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Menopause Hormonal Treatment market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Menopause Hormonal Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Menopause Hormonal Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Menopause Hormonal Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Menopause Hormonal Treatment Market by Company

Teva Pharmaceutical Industries

Novartis

Novo Nordisk

Merck

Eli Lilly And Company

Pfizer

Bayer

AbbVie

Theramex

Pure Encapsulations, Inc.

Emcure Pharmaceuticals

Cipla

Allergan

Menopause Hormonal Treatment Segment by Type

Table

Patch

Spray

Others

Menopause Hormonal Treatment Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Menopause Hormonal Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Menopause Hormonal Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Menopause Hormonal Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Menopause Hormonal Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Menopause Hormonal Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Menopause Hormonal Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Table Table 2. Major Company of Patch Table 3. Major Company of Spray Table 4. Major Company of Others Table 5. Global Menopause Hormonal Treatment Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Menopause Hormonal Treatment Sales by Type (2021-2026) & (tons) Table 7. Global Menopause Hormonal Treatment Sales Market Share in Volume by Type (2021-2026) Table 8. Global Menopause Hormonal Treatment Sales by Type (2021-2026) & (US$ Million) Table 9. Global Menopause Hormonal Treatment Sales Market Share in Value by Type (2021-2026) Table 10. Global Menopause Hormonal Treatment Price by Type (2021-2026) & (US$/ton) Table 11. Global Menopause Hormonal Treatment Sales by Type (2027-2032) & (tons) Table 12. Global Menopause Hormonal Treatment Sales Market Share in Volume by Type (2027-2032) Table 13. Global Menopause Hormonal Treatment Sales by Type (2027-2032) & (US$ Million) Table 14. Global Menopause Hormonal Treatment Sales Market Share in Value by Type (2027-2032) Table 15. Global Menopause Hormonal Treatment Price by Type (2027-2032) & (US$/ton) Table 16. North America Menopause Hormonal Treatment Sales by Type (2021-2026) & (tons) Table 17. North America Menopause Hormonal Treatment Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Menopause Hormonal Treatment Sales by Type (2021-2026) & (tons) Table 19. Europe Menopause Hormonal Treatment Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Menopause Hormonal Treatment Sales by Type (2021-2026) & (tons) Table 21. Asia-Pacific Menopause Hormonal Treatment Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Menopause Hormonal Treatment Sales by Type (2021-2026) & (tons) Table 23. Latin America Menopause Hormonal Treatment Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Menopause Hormonal Treatment Sales by Type (2021-2026) & (tons) Table 25. Middle East and Africa Menopause Hormonal Treatment Sales by Type (2021-2026) & (US$ Million) Table 26. Menopause Hormonal Treatment Industry Trends Table 27. Menopause Hormonal Treatment Industry Drivers Table 28. Menopause Hormonal Treatment Industry Opportunities and Challenges Table 29. Menopause Hormonal Treatment Industry Restraints Table 30. Global Menopause Hormonal Treatment Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Menopause Hormonal Treatment Revenue Market Share by Company (2021-2026) Table 32. Global Menopause Hormonal Treatment Sales by Company (2021-2026) & (tons) Table 33. Global Menopause Hormonal Treatment Sales Share by Company (2021-2026) Table 34. Global Menopause Hormonal Treatment Market Price by Company (2021-2026) & (US$/ton) Table 35. Global Menopause Hormonal Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Menopause Hormonal Treatment Major Company Production Sites and Headquarters Table 37. Global Menopause Hormonal Treatment Company, Product Type & Application Table 38. Global Menopause Hormonal Treatment Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Menopause Hormonal Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Menopause Hormonal Treatment Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Menopause Hormonal Treatment Sales by Region (2021-2026) & (tons) Table 43. Global Menopause Hormonal Treatment Sales Market Share in Volume by Region (2021-2026) Table 44. Global Menopause Hormonal Treatment Sales by Region (2021-2026) & (US$ Million) Table 45. Global Menopause Hormonal Treatment Sales Market Share in Value by Region (2021-2026) Table 46. Global Menopause Hormonal Treatment Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 47. Global Menopause Hormonal Treatment Sales by Region (2027-2032) & (tons) Table 48. Global Menopause Hormonal Treatment Sales Market Share in Volume by Region (2027-2032) Table 49. Global Menopause Hormonal Treatment Sales by Region (2027-2032) & (US$ Million) Table 50. Global Menopause Hormonal Treatment Sales Market Share in Value by Region (2027-2032) Table 51. Global Menopause Hormonal Treatment Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 52. Global Menopause Hormonal Treatment Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Menopause Hormonal Treatment Sales by Application (2021-2026) & (tons) Table 54. Global Menopause Hormonal Treatment Sales Market Share in Volume by Application (2021-2026) Table 55. Global Menopause Hormonal Treatment Sales by Application (2021-2026) & (US$ Million) Table 56. Global Menopause Hormonal Treatment Sales Market Share in Value by Application (2021-2026) Table 57. Global Menopause Hormonal Treatment Price by Application (2021-2026) & (US$/ton) Table 58. Global Menopause Hormonal Treatment Sales by Application (2027-2032) & (tons) Table 59. Global Menopause Hormonal Treatment Sales Market Share in Volume by Application (2027-2032) Table 60. Global Menopause Hormonal Treatment Sales by Application (2027-2032) & (US$ Million) Table 61. Global Menopause Hormonal Treatment Sales Market Share in Value by Application (2027-2032) Table 62. Global Menopause Hormonal Treatment Price by Application (2027-2032) & (US$/ton) Table 63. North America Menopause Hormonal Treatment Sales by Application (2021-2026) & (tons) Table 64. North America Menopause Hormonal Treatment Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Menopause Hormonal Treatment Sales by Application (2021-2026) & (tons) Table 66. Europe Menopause Hormonal Treatment Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Menopause Hormonal Treatment Sales by Application (2021-2026) & (tons) Table 68. Asia-Pacific Menopause Hormonal Treatment Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Menopause Hormonal Treatment Sales by Application (2021-2026) & (tons) Table 70. Latin America Menopause Hormonal Treatment Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Menopause Hormonal Treatment Sales by Application (2021-2026) & (tons) Table 72. Middle East and Africa Menopause Hormonal Treatment Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Pharmaceutical Industries Company Information Table 74. Teva Pharmaceutical Industries Business Overview Table 75. Teva Pharmaceutical Industries Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Industries Menopause Hormonal Treatment Product Portfolio Table 77. Teva Pharmaceutical Industries Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Novartis Menopause Hormonal Treatment Product Portfolio Table 82. Novartis Recent Development Table 83. Novo Nordisk Company Information Table 84. Novo Nordisk Business Overview Table 85. Novo Nordisk Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Novo Nordisk Menopause Hormonal Treatment Product Portfolio Table 87. Novo Nordisk Recent Development Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Merck Menopause Hormonal Treatment Product Portfolio Table 92. Merck Recent Development Table 93. Eli Lilly And Company Company Information Table 94. Eli Lilly And Company Business Overview Table 95. Eli Lilly And Company Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. Eli Lilly And Company Menopause Hormonal Treatment Product Portfolio Table 97. Eli Lilly And Company Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. Pfizer Menopause Hormonal Treatment Product Portfolio Table 102. Pfizer Recent Development Table 103. Bayer Company Information Table 104. Bayer Business Overview Table 105. Bayer Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. Bayer Menopause Hormonal Treatment Product Portfolio Table 107. Bayer Recent Development Table 108. AbbVie Company Information Table 109. AbbVie Business Overview Table 110. AbbVie Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 111. AbbVie Menopause Hormonal Treatment Product Portfolio Table 112. AbbVie Recent Development Table 113. Theramex Company Information Table 114. Theramex Business Overview Table 115. Theramex Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 116. Theramex Menopause Hormonal Treatment Product Portfolio Table 117. Theramex Recent Development Table 118. Pure Encapsulations, Inc. Company Information Table 119. Pure Encapsulations, Inc. Business Overview Table 120. Pure Encapsulations, Inc. Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 121. Pure Encapsulations, Inc. Menopause Hormonal Treatment Product Portfolio Table 122. Pure Encapsulations, Inc. Recent Development Table 123. Emcure Pharmaceuticals Company Information Table 124. Emcure Pharmaceuticals Business Overview Table 125. Emcure Pharmaceuticals Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 126. Emcure Pharmaceuticals Menopause Hormonal Treatment Product Portfolio Table 127. Emcure Pharmaceuticals Recent Development Table 128. Cipla Company Information Table 129. Cipla Business Overview Table 130. Cipla Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 131. Cipla Menopause Hormonal Treatment Product Portfolio Table 132. Cipla Recent Development Table 133. Allergan Company Information Table 134. Allergan Business Overview Table 135. Allergan Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 136. Allergan Menopause Hormonal Treatment Product Portfolio Table 137. Allergan Recent Development Table 138. North America Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 139. North America Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 140. North America Menopause Hormonal Treatment Sales Market Share by Country (2021-2026) Table 141. North America Menopause Hormonal Treatment Sales Forecast by Country (2027-2032) & (tons) Table 142. North America Menopause Hormonal Treatment Sales Market Share Forecast by Country (2027-2032) Table 143. North America Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Menopause Hormonal Treatment Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Menopause Hormonal Treatment Market Share by Country (2021-2026) Table 146. North America Menopause Hormonal Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Menopause Hormonal Treatment Market Share Forecast by Country (2027-2032) Table 148. Europe Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 149. Europe Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 150. Europe Menopause Hormonal Treatment Sales Market Share by Country (2021-2026) Table 151. Europe Menopause Hormonal Treatment Sales Forecast by Country (2027-2032) & (tons) Table 152. Europe Menopause Hormonal Treatment Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Menopause Hormonal Treatment Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Menopause Hormonal Treatment Market Share by Country (2021-2026) Table 156. Europe Menopause Hormonal Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Menopause Hormonal Treatment Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 160. Asia-Pacific Menopause Hormonal Treatment Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Menopause Hormonal Treatment Sales Forecast by Country (2027-2032) & (tons) Table 162. Asia-Pacific Menopause Hormonal Treatment Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Menopause Hormonal Treatment Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Menopause Hormonal Treatment Market Share by Country (2021-2026) Table 166. Asia-Pacific Menopause Hormonal Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Menopause Hormonal Treatment Market Share Forecast by Country (2027-2032) Table 168. Latin America Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 169. Latin America Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 170. Latin America Menopause Hormonal Treatment Sales Market Share by Country (2021-2026) Table 171. Latin America Menopause Hormonal Treatment Sales Forecast by Country (2027-2032) & (tons) Table 172. Latin America Menopause Hormonal Treatment Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Menopause Hormonal Treatment Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Menopause Hormonal Treatment Market Share by Country (2021-2026) Table 176. Latin America Menopause Hormonal Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Menopause Hormonal Treatment Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 180. Middle East and Africa Menopause Hormonal Treatment Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Menopause Hormonal Treatment Sales Forecast by Country (2027-2032) & (tons) Table 182. Middle East and Africa Menopause Hormonal Treatment Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Menopause Hormonal Treatment Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Menopause Hormonal Treatment Market Share by Country (2021-2026) Table 186. Middle East and Africa Menopause Hormonal Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Menopause Hormonal Treatment Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Menopause Hormonal Treatment Distributors List Table 191. Menopause Hormonal Treatment Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Menopause Hormonal Treatment Image Figure 2. Global Menopause Hormonal Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Menopause Hormonal Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Menopause Hormonal Treatment Sales (2021-2032) & (tons) Figure 5. Table Image Figure 6. Global Table Sales YoY Growth (2021-2032) & (tons) Figure 7. Patch Image Figure 8. Global Patch Sales YoY Growth (2021-2032) & (tons) Figure 9. Spray Image Figure 10. Global Spray Sales YoY Growth (2021-2032) & (tons) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (tons) Figure 13. Global Menopause Hormonal Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Menopause Hormonal Treatment Market Share by Type 2025 VS 2032 Figure 15. North America Menopause Hormonal Treatment Sales Market Share in Volume by Type in 2025 Figure 16. North America Menopause Hormonal Treatment Sales Market Share in Value by Type in 2025 Figure 17. Europe Menopause Hormonal Treatment Sales Market Share in Volume by Type in 2025 Figure 18. Europe Menopause Hormonal Treatment Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Menopause Hormonal Treatment Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Menopause Hormonal Treatment Sales Market Share in Value by Type in 2025 Figure 21. Latin America Menopause Hormonal Treatment Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Menopause Hormonal Treatment Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Menopause Hormonal Treatment Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Menopause Hormonal Treatment Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Menopause Hormonal Treatment Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (tons) Figure 29. Online Pharmacies Image Figure 30. Global Online Pharmacies Sales YoY Growth (2021-2032) & (tons) Figure 31. Hospital Pharmacies Image Figure 32. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (tons) Figure 33. Global Menopause Hormonal Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Menopause Hormonal Treatment Market Share by Application 2025 VS 2032 Figure 35. North America Menopause Hormonal Treatment Sales Market Share in Volume by Application in 2025 Figure 36. North America Menopause Hormonal Treatment Sales Market Share in Value by Application in 2025 Figure 37. Europe Menopause Hormonal Treatment Sales Market Share in Volume by Application in 2025 Figure 38. Europe Menopause Hormonal Treatment Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Menopause Hormonal Treatment Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Menopause Hormonal Treatment Sales Market Share in Value by Application in 2025 Figure 41. Latin America Menopause Hormonal Treatment Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Menopause Hormonal Treatment Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Menopause Hormonal Treatment Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Menopause Hormonal Treatment Sales Market Share in Value by Application in 2025 Figure 45. North America Menopause Hormonal Treatment Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 46. North America Menopause Hormonal Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Menopause Hormonal Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Menopause Hormonal Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Menopause Hormonal Treatment Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 50. Europe Menopause Hormonal Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Menopause Hormonal Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Menopause Hormonal Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Menopause Hormonal Treatment Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 54. Asia-Pacific Menopause Hormonal Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Menopause Hormonal Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Menopause Hormonal Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Menopause Hormonal Treatment Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 58. Latin America Menopause Hormonal Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Menopause Hormonal Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Menopause Hormonal Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Menopause Hormonal Treatment Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 62. Middle East and Africa Menopause Hormonal Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Menopause Hormonal Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Menopause Hormonal Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Menopause Hormonal Treatment Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Menopause Hormonal Treatment Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Table
  • Patch
  • Spray
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Teva Pharmaceutical Industries
  • Novartis
  • Novo Nordisk
  • Merck
  • Eli Lilly And Company
  • Pfizer
  • Bayer
  • AbbVie
  • Theramex
  • Pure Encapsulations, Inc.
  • Emcure Pharmaceuticals
  • Cipla
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Menopause Hormonal Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Menopause Hormonal Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Menopause Hormonal Treatment Market by Type
  6. 1.3.1 Table
  7. 1.3.2 Patch
  8. 1.3.3 Spray
  9. 1.3.4 Others
  10. 1.4 Global Menopause Hormonal Treatment Market Size by Type
  11. 1.4.1 Global Menopause Hormonal Treatment Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Menopause Hormonal Treatment Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Menopause Hormonal Treatment Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Menopause Hormonal Treatment Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Menopause Hormonal Treatment Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Menopause Hormonal Treatment Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Menopause Hormonal Treatment Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Menopause Hormonal Treatment Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Menopause Hormonal Treatment Industry Trends
  2. 2.2 Menopause Hormonal Treatment Industry Drivers
  3. 2.3 Menopause Hormonal Treatment Industry Opportunities and Challenges
  4. 2.4 Menopause Hormonal Treatment Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Menopause Hormonal Treatment Revenue (2021-2026)
  2. 3.2 Global Top Players by Menopause Hormonal Treatment Sales (2021-2026)
  3. 3.3 Global Top Players by Menopause Hormonal Treatment Price (2021-2026)
  4. 3.4 Global Menopause Hormonal Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Menopause Hormonal Treatment Major Company Production Sites & Headquarters
  6. 3.6 Global Menopause Hormonal Treatment Company, Product Type & Application
  7. 3.7 Global Menopause Hormonal Treatment Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Menopause Hormonal Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Menopause Hormonal Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Menopause Hormonal Treatment Tier 1, Tier 2, and Tier 3
4 Menopause Hormonal Treatment Regional Status and Outlook
  1. 4.1 Global Menopause Hormonal Treatment Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Menopause Hormonal Treatment Historic Market Size by Region
  3. 4.2.1 Global Menopause Hormonal Treatment Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Menopause Hormonal Treatment Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Menopause Hormonal Treatment Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Menopause Hormonal Treatment Forecasted Market Size by Region
  7. 4.3.1 Global Menopause Hormonal Treatment Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Menopause Hormonal Treatment Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Menopause Hormonal Treatment Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Menopause Hormonal Treatment by Application
  1. 5.1 Menopause Hormonal Treatment Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Menopause Hormonal Treatment Market Size by Application
  6. 5.2.1 Global Menopause Hormonal Treatment Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Menopause Hormonal Treatment Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Menopause Hormonal Treatment Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Menopause Hormonal Treatment Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Menopause Hormonal Treatment Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Menopause Hormonal Treatment Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Menopause Hormonal Treatment Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Menopause Hormonal Treatment Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Menopause Hormonal Treatment Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Menopause Hormonal Treatment Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Novo Nordisk
  14. 6.3.1 Novo Nordisk Company Information
  15. 6.3.2 Novo Nordisk Business Overview
  16. 6.3.3 Novo Nordisk Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novo Nordisk Menopause Hormonal Treatment Product Portfolio
  18. 6.3.5 Novo Nordisk Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Menopause Hormonal Treatment Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Eli Lilly And Company
  26. 6.5.1 Eli Lilly And Company Company Information
  27. 6.5.2 Eli Lilly And Company Business Overview
  28. 6.5.3 Eli Lilly And Company Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly And Company Menopause Hormonal Treatment Product Portfolio
  30. 6.5.5 Eli Lilly And Company Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Menopause Hormonal Treatment Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Bayer
  38. 6.7.1 Bayer Company Information
  39. 6.7.2 Bayer Business Overview
  40. 6.7.3 Bayer Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bayer Menopause Hormonal Treatment Product Portfolio
  42. 6.7.5 Bayer Recent Developments
  43. 6.8 AbbVie
  44. 6.8.1 AbbVie Company Information
  45. 6.8.2 AbbVie Business Overview
  46. 6.8.3 AbbVie Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AbbVie Menopause Hormonal Treatment Product Portfolio
  48. 6.8.5 AbbVie Recent Developments
  49. 6.9 Theramex
  50. 6.9.1 Theramex Company Information
  51. 6.9.2 Theramex Business Overview
  52. 6.9.3 Theramex Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Theramex Menopause Hormonal Treatment Product Portfolio
  54. 6.9.5 Theramex Recent Developments
  55. 6.10 Pure Encapsulations, Inc.
  56. 6.10.1 Pure Encapsulations, Inc. Company Information
  57. 6.10.2 Pure Encapsulations, Inc. Business Overview
  58. 6.10.3 Pure Encapsulations, Inc. Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Pure Encapsulations, Inc. Menopause Hormonal Treatment Product Portfolio
  60. 6.10.5 Pure Encapsulations, Inc. Recent Developments
  61. 6.11 Emcure Pharmaceuticals
  62. 6.11.1 Emcure Pharmaceuticals Company Information
  63. 6.11.2 Emcure Pharmaceuticals Business Overview
  64. 6.11.3 Emcure Pharmaceuticals Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Emcure Pharmaceuticals Menopause Hormonal Treatment Product Portfolio
  66. 6.11.5 Emcure Pharmaceuticals Recent Developments
  67. 6.12 Cipla
  68. 6.12.1 Cipla Company Information
  69. 6.12.2 Cipla Business Overview
  70. 6.12.3 Cipla Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Cipla Menopause Hormonal Treatment Product Portfolio
  72. 6.12.5 Cipla Recent Developments
  73. 6.13 Allergan
  74. 6.13.1 Allergan Company Information
  75. 6.13.2 Allergan Business Overview
  76. 6.13.3 Allergan Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Allergan Menopause Hormonal Treatment Product Portfolio
  78. 6.13.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Menopause Hormonal Treatment Sales by Country
  2. 7.1.1 North America Menopause Hormonal Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Menopause Hormonal Treatment Sales by Country (2021-2026)
  4. 7.1.3 North America Menopause Hormonal Treatment Sales Forecast by Country (2027-2032)
  5. 7.2 North America Menopause Hormonal Treatment Market Size by Country
  6. 7.2.1 North America Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Menopause Hormonal Treatment Market Size by Country (2021-2026)
  8. 7.2.3 North America Menopause Hormonal Treatment Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Menopause Hormonal Treatment Sales by Country
  2. 8.1.1 Europe Menopause Hormonal Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Menopause Hormonal Treatment Sales by Country (2021-2026)
  4. 8.1.3 Europe Menopause Hormonal Treatment Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Menopause Hormonal Treatment Market Size by Country
  6. 8.2.1 Europe Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Menopause Hormonal Treatment Market Size by Country (2021-2026)
  8. 8.2.3 Europe Menopause Hormonal Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Menopause Hormonal Treatment Sales by Country
  2. 9.1.1 Asia-Pacific Menopause Hormonal Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Menopause Hormonal Treatment Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Menopause Hormonal Treatment Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Menopause Hormonal Treatment Market Size by Country
  6. 9.2.1 Asia-Pacific Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Menopause Hormonal Treatment Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Menopause Hormonal Treatment Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Menopause Hormonal Treatment Sales by Country
  2. 10.1.1 South America Menopause Hormonal Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Menopause Hormonal Treatment Sales by Country (2021-2026)
  4. 10.1.3 South America Menopause Hormonal Treatment Sales Forecast by Country (2027-2032)
  5. 10.2 South America Menopause Hormonal Treatment Market Size by Country
  6. 10.2.1 South America Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Menopause Hormonal Treatment Market Size by Country (2021-2026)
  8. 10.2.3 South America Menopause Hormonal Treatment Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Menopause Hormonal Treatment Sales by Country
  2. 11.1.1 Middle East and Africa Menopause Hormonal Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Menopause Hormonal Treatment Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Menopause Hormonal Treatment Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Menopause Hormonal Treatment Market Size by Country
  6. 11.2.1 Middle East and Africa Menopause Hormonal Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Menopause Hormonal Treatment Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Menopause Hormonal Treatment Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Menopause Hormonal Treatment Value Chain Analysis
  2. 12.1.1 Menopause Hormonal Treatment Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Menopause Hormonal Treatment Production Mode & Process
  7. 12.2 Menopause Hormonal Treatment Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Menopause Hormonal Treatment Distributors
  10. 12.2.3 Menopause Hormonal Treatment Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst